HIV-1 Superinfection Occurs Less Frequently Than Initial Infection in a Cohort of High-Risk Kenyan Women

English version České info

HIV superinfection (reinfection) has been reported in several settings, but no study has been designed and powered to rigorously compare its incidence to that of initial infection. Determining whether HIV infection reduces the risk of superinfection is critical to understanding whether an immune response to natural HIV infection is protective. This study compares the incidence of initial infection and superinfection in a prospective seroincident cohort of high-risk women in Mombasa, Kenya. A next-generation sequencing-based pipeline was developed to screen 129 women for superinfection. Longitudinal plasma samples at <6 months, >2 years and one intervening time after initial HIV infection were analyzed. Amplicons in three genome regions were sequenced and a median of 901 sequences obtained per gene per timepoint. Phylogenetic evidence of polyphyly, confirmed by pairwise distance analysis, defined superinfection. Superinfection timing was determined by sequencing virus from intervening timepoints. These data were combined with published data from 17 additional women in the same cohort, totaling 146 women screened. Twenty-one cases of superinfection were identified for an estimated incidence rate of 2.61 per 100 person-years (pys). The incidence rate of initial infection among 1910 women in the same cohort was 5.75 per 100pys. Andersen-Gill proportional hazards models were used to compare incidences, adjusting for covariates known to influence HIV susceptibility in this cohort. Superinfection incidence was significantly lower than initial infection incidence, with a hazard ratio of 0.47 (CI 0.29–0.75, p = 0.0019). This lower incidence of superinfection was only observed >6 months after initial infection. This is the first adequately powered study to report that HIV infection reduces the risk of reinfection, raising the possibility that immune responses to natural infection are partially protective. The observation that superinfection risk changes with time implies a window of protection that coincides with the maturation of HIV-specific immunity.

Vyšlo v časopise: HIV-1 Superinfection Occurs Less Frequently Than Initial Infection in a Cohort of High-Risk Kenyan Women. PLoS Pathog 9(8): e32767. doi:10.1371/journal.ppat.1003593
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1003593

Souhrn

Zdroje

1. BakerBM, BlockBL, RothchildAC, WalkerBD (2009) Elite control of HIV infection: implications for vaccine design. Expert Opin Biol Ther 9: 55–69 doi:10.1517/14712590802571928

2. ChohanBH, PiantadosiA, OverbaughJ (2010) HIV-1 superinfection and its implications for vaccine design. Curr HIV Res 8: 596–601.

3. SmithDM, WongJK, HightowerGK, IgnacioCC, KoelschKK, et al. (2004) Incidence of HIV superinfection following primary infection. JAMA 292: 1177–1178 doi:10.1001/jama.292.10.1177

4. WatersL, SmitE (2012) HIV-1 superinfection. Curr Opin Infect Dis 25: 42–50 doi:10.1097/QCO.0b013e32834ef5af

5. ChohanB, LavreysL, RainwaterSMJ, OverbaughJ (2005) Evidence for frequent reinfection with human immunodeficiency virus type 1 of a different subtype. Journal of Virology 79: 10701–10708 doi:10.1128/JVI.79.16.10701-10708.2005

6. AltfeldM, AllenTM, YuXG, JohnstonMN, AgrawalD, et al. (2002) HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus. Nature 420: 434–439 doi:10.1038/nature01200

7. JostS, BernardM-C, KaiserL, YerlyS, HirschelB, et al. (2002) A patient with HIV-1 superinfection. N Engl J Med 347: 731–736 doi:10.1056/NEJMoa020263

8. ReddAD, MullisCE, SerwaddaD, KongX, MartensC, et al. (2012) The rates of HIV superinfection and primary HIV incidence in a general population in Rakai, Uganda. J INFECT DIS 206: 267–274 doi:10.1093/infdis/jis325

9. RamosA, HuDJ, NguyenL, PhanK-O, VanichseniS, et al. (2002) Intersubtype human immunodeficiency virus type 1 superinfection following seroconversion to primary infection in two injection drug users. Journal of Virology 76: 7444–7452.

10. KoelschKK, SmithDM, LittleSJ, IgnacioCC, MacaranasTR, et al. (2003) Clade B HIV-1 superinfection with wild-type virus after primary infection with drug-resistant clade B virus. AIDS 17: F11–F16 doi:10.1097/01.aids.0000060361.78202.4c

11. van der KuylAC, KozaczynskaK, van den BurgR, ZorgdragerF, BackN, et al. (2005) Triple HIV-1 infection. N Engl J Med 352: 2557–2559 doi:10.1056/NEJM200506163522420

12. PiantadosiA, NgayoMO, ChohanB, OverbaughJ (2008) Examination of a second region of the HIV type 1 genome reveals additional cases of superinfection. AIDS Res Hum Retroviruses 24: 1221 doi:10.1089/aid.2008.0100

13. ReddAD, QuinnTC, TobianAA (2013) Frequency and implications of HIV superinfection. The Lancet Infectious Diseases 13: 622–628 doi:10.1016/S1473-3099(13)70066-5

14. TsuiR, HerringBL, BarbourJD, GrantRM, BacchettiP, et al. (2004) Human immunodeficiency virus type 1 superinfection was not detected following 215 years of injection drug user exposure. Journal of Virology 78: 94–103.

15. RachingerA, ManyengaP, BurgerJA, Derks Van De VenTLP, StolteIG, et al. (2011) Low Incidence of HIV-1 Superinfection Even After Episodes of Unsafe Sexual Behavior of Homosexual Men in the Amsterdam Cohort Studies on HIV Infection and AIDS. Journal of Infectious Diseases 203: 1621–1628 doi:10.1093/infdis/jir164

16. GonzalesMJ, DelwartE, RheeS-Y, TsuiR, ZolopaAR, et al. (2003) Lack of detectable human immunodeficiency virus type 1 superinfection during 1072 person-years of observation. J INFECT DIS 188: 397–405 doi:10.1086/376534

17. PiantadosiA, ChohanB, ChohanV, McClellandRS, OverbaughJ (2007) Chronic HIV-1 Infection Frequently Fails to Protect against Superinfection. PLoS Pathog 3: e177 doi:10.1371/journal.ppat.0030177.st002

18. KraftCS, BasuD, HawkinsPA, HraberPT, ChombaE, et al. (2012) Timing and source of subtype-C HIV-1 superinfection in the newly infected partner of Zambian couples with disparate viruses. Retrovirology 9: 22 doi:10.1186/1742-4690-9-22

19. van der KuylAC, CornelissenM (2007) Identifying HIV-1 dual infections. Retrovirology 4: 67 doi:10.1186/1742-4690-4-67

20. PacoldM, SmithD, LittleS, ChengPM, JordanP, et al. (2010) Comparison of methods to detect HIV dual infection. AIDS Res Hum Retroviruses 26: 1291–1298 doi:10.1089/aid.2010.0042

21. ReddAD, Collinson-StrengA, MartensC, RicklefsS, MullisCE, et al. (2011) Identification of HIV superinfection in seroconcordant couples in Rakai, Uganda, by use of next-generation deep sequencing. J Clin Microbiol 49: 2859–2867 doi:10.1128/JCM.00804-11

22. MartinHL, NyangePM, RichardsonBA, LavreysL, MandaliyaK, et al. (1998) Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1. J INFECT DIS 178: 1053–1059.

23. BaetenJM, RichardsonBA, MartinHL, NyangePM, LavreysL, et al. (2000) Trends in HIV-1 incidence in a cohort of prostitutes in Kenya: implications for HIV-1 vaccine efficacy trials. J Acquir Immune Defic Syndr 24: 458–464.

24. SmithDM, RichmanDD, LittleSJ (2005) HIV superinfection. J INFECT DIS 192: 438–444 doi:10.1086/431682

25. RainwaterS, DeVangeS, SagarM, Ndinya-AcholaJ, MandaliyaK, et al. (2005) No evidence for rapid subtype C spread within an epidemic in which multiple subtypes and intersubtype recombinants circulate. AIDS Res Hum Retroviruses 21: 1060–1065 doi:10.1089/aid.2005.21.1060

26. KlassePJ, MooreJP (2012) Good CoP, bad CoP? Interrogating the immune responses to primate lentiviral vaccines. Retrovirology 9: 1–1 doi:10.1186/1742-4690-9-80

27. SmithDM, StrainMC, FrostSDW, PillaiSK, WongJK, et al. (2006) Lack of neutralizing antibody response to HIV-1 predisposes to superinfection. Virology 355: 1–5 doi:10.1016/j.virol.2006.08.009

28. BasuD, KraftCS, MurphyMK, CampbellPJ, YuT, et al. (2012) HIV-1 subtype C superinfected individuals mount low autologous neutralizing antibody responses prior to intrasubtype superinfection. Retrovirology 9: 76 doi:10.1186/1742-4690-9-76

29. BlishCA, DoganOC, DerbyNR, NguyenM-A, ChohanB, et al. (2008) Human immunodeficiency virus type 1 superinfection occurs despite relatively robust neutralizing antibody responses. Journal of Virology 82: 12094–12103 doi:10.1128/JVI.01730-08

30. ForthalDN, LanducciG, ChohanB, RichardsonBA, McClellandRS, et al. (2013) Antibody-Dependent Cell-Mediated Virus Inhibition Antibody Activity Does Not Correlate With Risk of HIV-1 Superinfection. J Acquir Immune Defic Syndr 63: 31–33 doi:10.1097/QAI.0b013e3182874d41

31. BlishCA, DoganOC, JaokoW, McClellandRS, MandaliyaK, et al. (2012) Cellular immune responses and susceptibility to HIV-1 superinfection: a case-control study. AIDS 26: 643–646 doi:10.1097/QAD.0b013e3283509a0b

32. QuinceC, LanzenA, DavenportRJ, TurnbaughPJ (2011) Removing noise from pyrosequenced amplicons. BMC bioinformatics 12: 38 doi:10.1186/1471-2105-12-38

33. EdgarRC, HaasBJ, ClementeJC, QuinceC, KnightR (2011) UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 27: 2194–2200 doi:10.1093/bioinformatics/btr381

34. MatsenFA, KodnerRB, ArmbrustEV (2010) pplacer: linear time maximum-likelihood and Bayesian phylogenetic placement of sequences onto a fixed reference tree. BMC bioinformatics 11: 538 doi:10.1186/1471-2105-11-538

35. MatsenFA, GallagherA, McCoyC (2012) Minimizing the average distance to a closest leaf in a phylogenetic tree. Systematic Biology In press.

36. EddySR (2011) Accelerated Profile HMM Searches. PLoS Comput Biol 7: e1002195 doi:10.1371/journal.pcbi.1002195

37. DrummondAJ, RambautA (2007) BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol 7: 214 doi:10.1186/1471-2148-7-214

38. ParadisE, ClaudeJ, StrimmerK (2004) APE: Analyses of Phylogenetics and Evolution in R language. Bioinformatics 20: 289–290 doi:10.1093/bioinformatics/btg412